Your browser doesn't support javascript.
loading
The role of the hematopoietic stem/progenitor cells-derived extracellular vesicles in hematopoiesis.
Fathi, Ezzatollah; Valipour, Behnaz; Jafari, Sevda; Kazemi, Abdolhassan; Montazersaheb, Soheila; Farahzadi, Raheleh.
Afiliación
  • Fathi E; Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.
  • Valipour B; Department of Basic Sciences and Health, Sarab Faculty of Medical Sciences, Sarab, Iran.
  • Jafari S; Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Kazemi A; Medical Philosophy and History Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Montazersaheb S; Department of Parasitology and Mycology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Farahzadi R; Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Heliyon ; 10(15): e35051, 2024 Aug 15.
Article en En | MEDLINE | ID: mdl-39157371
ABSTRACT
Hematopoietic stem cells (HSCs) are tightly regulated by specific microenvironments called niches to produce an appropriate number of mature blood cell types. Self-renewal and differentiation are two hallmarks of hematopoietic stem and progenitor cells, and their balance is critical for proper functioning of blood and immune cells throughout life. In addition to cell-intrinsic regulation, extrinsic cues within the bone marrow niche and systemic factors also affect the fate of HSCs. Despite this, many paracrine and endocrine factors that influence the function of hematopoietic cells remain unknown. In hematological malignancies, malignant cells remodel their niche into a permissive environment to enhance the survival of leukemic cells. These events are accompanied by loss of normal hematopoiesis. It is well known that extracellular vehicles (EVs) mediate intracellular interactions under physiological and pathological conditions. In other words, EVs transfer biological information to surrounding cells and contribute not only to physiological functions but also to the pathogenesis of some diseases, such as cancers. Therefore, a better understanding of cell-to-cell interactions may lead to identification of potential therapeutic targets. Recent reports have suggested that EVs are evolutionarily conserved constitutive mediators that regulate hematopoiesis. Here, we focus on the emerging roles of EVs in normal and pathological conditions, particularly in hematological malignancies. Owing to the high abundance of EVs in biological fluids, their potential use as biomarkers and therapeutic tools is discussed.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Heliyon Año: 2024 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Heliyon Año: 2024 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Reino Unido